Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Parkinson's disease and depression].

K Kurokawa1, T Yuasa

  • 1Department of Neurology, Kohnodai Hospital.

Nihon Rinsho. Japanese Journal of Clinical Medicine
|November 9, 2000
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Identification of a cDNA encoding a thiazide-sensitive sodium-chloride cotransporter from the human and its mRNA expression in various tissues.

Biochemical and biophysical research communications·1996
Same author

Stage-specific elevated expression of the genes for hepatocyte growth factor, keratinocyte growth factor, and their receptors during the morphogenesis and differentiation of rat stomach mucosa.

Biochemical and biophysical research communications·1996
Same author

Large spleno-caval shunt not accompanied by cirrhosis or encephalopathy.

Journal of gastroenterology·1996
Same author

Co-induction of DNA relaxation and synthesis of DnaK and GroEL proteins in Escherichia coli by expression of LetD (CcdB) protein, an inhibitor of DNA gyrase encoded by the F factor.

Molecular & general genetics : MGG·1996
Same author

Complementary DNA cloning and sequencing of rat enteropeptidase and tissue distribution of its mRNA.

Biochemical and biophysical research communications·1996
Same author

Primary structure of light and heavy chain variable regions of antibodies recognizing phosphorylated vimentins.

Biochemical and biophysical research communications·1996
Same journal

[Development of novel therapeutics for multiple myeloma and improvement of drug lag].

Nihon rinsho. Japanese journal of clinical medicine·2019
Same journal

[Clinical pharmacy services to patients of immunomodulatory drugs].

Nihon rinsho. Japanese journal of clinical medicine·2019
Same journal

[Therapeutic drug monitoring of the new anti-myeloma drugs in the treatment of multiple myeloma].

Nihon rinsho. Japanese journal of clinical medicine·2019
Same journal

[Prognostic value of minimal residual disease assessment using next-generation sequencing in multiple myeloma].

Nihon rinsho. Japanese journal of clinical medicine·2019
Same journal

[The evaluation of minimal residual disease in multiple myeloma by an allele-specific oligonucleotide real-time PCR].

Nihon rinsho. Japanese journal of clinical medicine·2019
Same journal

[Evaluation of minimal residual disease in myeloma by multiparametric flow cytometry].

Nihon rinsho. Japanese journal of clinical medicine·2019
See all related articles

Depression affects up to 40% of Parkinson's disease patients, often resisting medication. Transcranial magnetic stimulation (TMS) shows promise as an effective, easily administered therapy for this challenging comorbidity.

Area of Science:

  • Neurology
  • Psychiatry

Context:

  • Parkinson's disease (PD) frequently co-occurs with depression, affecting up to 40% of patients.
  • Depressive symptoms in PD patients can be severe and often do not respond well to pharmacotherapy.

Purpose:

  • To explore the efficacy of non-pharmacological treatments for depression in Parkinson's disease patients.
  • To evaluate Transcranial Magnetic Stimulation (TMS) as a therapeutic option for comorbid depression in PD.

Summary:

  • Electroconvulsive therapy (ECT) has demonstrated effectiveness in treating drug-resistant depression and improving motor symptoms in Parkinson's disease.
  • Transcranial Magnetic Stimulation (TMS) is emerging as a valuable, outpatient-friendly tool for depression therapy.
  • TMS presents a significant potential contribution to managing depression in individuals with Parkinson's disease.

Related Experiment Videos

Impact:

  • Highlights the need for alternative depression treatments in Parkinson's disease.
  • Positions TMS as a promising, accessible therapeutic modality for this patient population.
  • Suggests improved quality of life for Parkinson's patients experiencing depression.